(Q36592133)

15 August 2017

1 reference

title

Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'? (English)

1 reference

15 August 2017

0 references

1 reference

Perl J

1

1 reference

15 August 2017

Unruh ML

series ordinal

2

1 reference

15 August 2017

Chan CT

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

13 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

70

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1687-1693

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001791

15 August 2017

exact match

0 references

cites work

Sleep complaints are common in a dialysis unit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

A Comparison of Reported Sleep Disorders in Patients on Chronic Hemodialysis and Continuous Peritoneal Dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep quality and clinical correlates in patients on maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Test-retest reliability of the MSLT.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Excessive daytime sleepiness in man: Multiple sleep latency measurement in narcoleptic and control subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Daytime sleepiness in stable hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea and daytime sleepiness in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Go to bed and get a good night's sleep: you need your rest!

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep disturbances in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Correlations between EEG and chemical changes in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Serum melatonin and 6-sulfatoxymelatonin in end-stage renal disease: effect of hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Amino acid metabolism in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Hemodialysis disrupts basic sleep regulatory mechanisms: building hypotheses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Disordered sleep and noncompliance in a patient with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

One negative polysomnogram does not exclude obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Hypopnea, a floating metric: implications for prevalence, morbidity estimates, and case finding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

The occurrence of sleep-disordered breathing among middle-aged adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea syndrome in chronic renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea incidence in maintenance hemodialysis patients: influence of dialysate buffer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Branched-chain amino acid in chronic renal failure patients: Respiratory and sleep effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Effect of chronic renal failure on skeletal and diaphragmatic muscle contraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea and heart failure: Part I: obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea and heart failure: Part II: central sleep apnea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Quality of life consequences of sleep-disordered breathing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea and hypertension. A population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Prospective study of the association between sleep-disordered breathing and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Association of sleep apnoea with myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Obstructive sleep apnea: implications for cardiac and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Nocturnal hypoxemia: a neglected cardiovascular risk factor in end-stage renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure--a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Reversal of sleep apnea hypopnea syndrome in end-stage renal disease after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Epidemiology of restless legs symptoms in adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless Legs Syndrome among working-aged women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless legs syndrome in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless legs syndrome in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Iron status and restless legs syndrome in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

MRI measurement of brain iron in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Multiple blood donations associated with iron deficiency in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Possible relation between restless legs and anaemia in renal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

L-dopa in uremic patients with the restless legs syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

An overview of levodopa in the management of restless legs syndrome in a dialysis population: pharmacokinetics, clinical trials, and complications of therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Effect of pergolide on restless legs and leg movements in sleep in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Restless Legs Syndrome in patients after renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Long-term course of restless legs syndrome in dialysis patients after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001791

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001791

1 reference

Dimensions Publication ID

15 August 2017

1035337150

0 references

1 reference